Antimicrobial Resistance Diagnostics Market

Antimicrobial Resistance Diagnostics Market

The global antimicrobial resistance (AMR) diagnostics market is poised for substantial expansion over the coming years as public health systems, pharmaceutical companies, and governments worldwide intensify efforts to combat the growing threat of antimicrobial resistance. According to the latest industry projections, the market is expected to grow at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032, increasing from US$4,830.7 million in 2025 to an estimated US$7,620.1 million by 2032. The steady trajectory underscores the rising importance of accurate and rapid diagnostic solutions in addressing the global health crisis posed by resistant pathogens.